Interim Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Dec. 30, 2022	Dec. 31, 2021
Revenue:
Revenue	$ 334,921	$ 351,633
Total revenue	334,921	351,633
Cost of revenue:
Total cost of revenue	34,450	32,709
Gross margin	300,471	318,924
Operating expenses:
Research and development	64,450	68,824
Sales and marketing	82,205	97,170
General and administrative	59,972	62,444
Restructuring credits	(244)	(95)
Total operating expenses	206,383	228,343
Operating income	94,088	90,581
Other income/(expense):
Interest income	4,878	716
Interest expense	(81)	(84)
Other income, net	1,097	229
Total other income	5,894	861
Income before income taxes	99,982	91,442
Provision for income taxes	(20,534)	(11,432)
Net income including controlling interest	79,448	80,010
Less: net (income)/loss attributable to controlling interest	(73)	4
Net income attributable to Dolby Laboratories, Inc.	$ 79,375	$ 80,014
Net income per share:
Basic (in usd per share)	$ 0.83	$ 0.79
Diluted (in usd per share)	$ 0.82	$ 0.77
Weighted-average shares outstanding:
Basic (in shares)	95,905	101,230
Diluted (in shares)	97,047	103,801
Cash dividend declared per common share (in dollars per share)	$ 0.27	$ 0.25
Cash dividend paid per common share (in dollars per share)	$ 0.27	$ 0.25
Licensing
Revenue:
Revenue	$ 308,011	$ 332,284
Cost of revenue:
Cost of revenue	13,359	14,935
Products and services
Revenue:
Revenue	26,910	19,349
Cost of revenue:
Cost of revenue	$ 21,091	$ 17,774